Battelle   Report issue

For profit Phase 1
Founded: Columbus OH United States (1923)
Status: No NME R&D (1923)

Organization Overview

First Clinical Trial
2017
NCT02961309
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Battelle | Battelle Memorial Institute